Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
During this time, you will be supported by our experienced medical team and have access to counseling and a custom blended formula to enhance your weight loss journey
What UK Patients Should Know About Retatrutide's Development Retatrutide is not approved by the MHRA or EMA and cannot be legally prescribed or dispensed in the UK
They are classified as food supplements and are not part of standard NHS obesity treatment pathways, which prioritise lifestyle modification and licensed medications such as orlistat or semaglutide
Ideal Candidates for OMMs Obesity medications may be ideal for: BMI 2735 kg/m with comorbidities Patients unwilling for surgery Younger patients with early obesity Patients requiring moderate weight reduction Individuals with high surgical risk Bridge therapy before surgery For these patients, medications can delay or potentially avoid surgery
Nature 579 , 609614 (2020)
